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MicroRNAs can promote translation of specific mRNAs in quiescent (G0) mammalian cells and immature
Xenopus laevis oocytes. We report that microRNA-mediated upregulation of target mRNAs in oocytes is
dependent on nuclear entry of the microRNA; cytoplasmically-injected microRNA repress target mRNAs.
Components of the activation microRNP, AGO, FXR1 (FXR1-iso-a) and miR16 are present in the nucleus
and cytoplasm. Importantly, microRNA target mRNAs for upregulation, Myt1, TNFa and a reporter
bearingtheTNFaAU-rich,microRNAtargetsequence,areassociatedwithAGOinimmatureoocytenuclei
andAGO2inG0humannuclei,respectively.mRNAsthatarerepressedorlacktargetsitesarenotassociated
with nuclear AGO. Crosslinking-coupled immunopurification revealed greater association of AGO2 with
FXR1in the nucleus compared tocytoplasm. Consistently, overexpressionof FXR1-iso-a rescues activation
ofcytoplasmically-injected RNAsandinlowdensity,proliferatingcells.Thesedataindicatetheimportance
of a compartmentalized AGO2-FXR1-iso-a complex for selective recruitment for microRNA-mediated
upregulation.
M
icroRNAs are small, non-coding RNAs that function as post-transcriptional regulators of gene express-
ion upon recruitment into effector complexes (microRNA protein complexes or microRNPs), which
containacoreArgonauteprotein,AGO.MicroRNPsrecognizethetargetmRNA,normallywithinits39-
UTR,inasequencespecificmannerandexerteffectsdirectedbythenatureofthebasepairing
3,7.MicroRNAshave
beenprimarilydemonstratedtocausedownregulation ofmRNAexpression
7;however,undercertainconditions,
suchasquiescence,distinctmRNAsdemonstratemicroRNA-mediatedupregulatedtranslation
17,22,26,31,42,47,52–56or
relief of repression by microRNAs
5,27,48.
Quiescence refers tothe reversible, non-dividing G0and G0-like states thatdividing cells can enter forperiods
oftimeduring whichtheyexhibitspecific geneexpression
12.LikeG0cells,theXenopuslaevisprophaseI-arrested
immature folliculated oocyte does not proliferate or replicate DNA and, as in some G0 cells, is maintained by
cAMP/PKA signaling
6,43.We previously demonstrated that adistinct microRNPcomprising AGO2, microRNAs
and a specific isoform of the Fragile-x-mental retardation related protein 1 (FXR1) family of proteins, called
FXR1-iso-a, can elicit translation upregulation of minimal target reporters and of specific mRNA targets in
quiescent mammalian cells
53–56 and in quiescent-like Xenopus laevis immature folliculated stage IV-VI oocytes
38.
Other groups revealed that specific microRNAs may activate translation of select transcripts including TNFa in
quiescence and quiescent-like states
17,31,52,53.
We demonstrated that microRNA-dependent activation of the Xenopus Myt1 mRNA (via miR16 microRNA)
is required in part to maintain the immature state. As in mammalian G0 cells, a Xenopus Argonaute (AGO) and
FXR1 are required for translation upregulation by microRNAs in immature folliculated oocytes
38. Argonaute
slicer activity was reported to be absent in oocytes. An AGO protein, recognized by an antibody that detects the
AGOPIWIdomainispresentinlimitingamountsbutnotrequiredforcleavageactivityintheoocyte
35,suggesting
that oocytes may harbor microRNAs to conduct cleavage-independent regulatory functions, such as translation
activation.
Here,wereportthatanuclearmicroRNP,comprisingAGO2andFXR1-iso-a,associateswithspecificmRNAs,
leading to their upregulated expression in immature, folliculated oocytes and in human G0 cells. We show that
microRNAs are required to be injected into folliculated oocyte germinal vesicles (GV) or nuclei to demonstrate
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sionof thesemRNAs. The components ofthe activationcomplex for
endogenous Myt1 mRNA—AGO, FXR1 and miR16
38—are present
in the nucleus of immature oocytes. Consistently, Xenopus AGO is
associatedwithendogenousMyt1mRNAinisolatedoocytenuclei,as
is human AGO2 with TNFa mRNA or with a reporter bearing its
AU-rich microRNA target sequence in G0 mammalian nuclei, but
notinproliferating cellnuclei.XenopusCyclinA1
32and mammalian
Cyclin E mRNAs
34, which are repressed in immature oocytes and
mammalian G0, are not recruited to the nuclear AGO/AGO2 com-
plex, suggesting that recruitment to the nuclear complex contributes
to selection of target mRNAs for microRNA-mediated activation.
AGO2 and FXR1, previously reported to be present in mamma-
lian cell nuclei
1,2,8,14,15,28,41,49,50,57,60, interact to a greater extent in the
nuclei of oocytes and mammalian cells compared to the cytoplasm.
Importantly,overexpressionofFXR1-iso-aincreasesAGOlevelsand
the activation complex in the cytoplasm and can rescue activation
aftercytoplasmicinjectionorinlowdensityproliferatingcells.These
data indicate that selective recruitment of specific microRNAs and
targetsbyacompartmentalizedAGO2-FXR1-iso-acomplex,present
in the nucleus or upon overexpression, leads to activation of target
mRNA expression.
Results
Translation upregulation is observed upon introduction of the
microRNA and mRNA into the nucleus but not into the cyto-
plasm. Our previous results demonstrated that immature follicu-
lated Xenopus laevis oocytes showed activated expression of Myt1
mRNA injected into the nucleus in response to endogenous micro-
RNA, miR16, and of CX, a Luciferase reporter bearing four artificial
microRNA sites, injected as a DNA plasmid along with its
corresponding synthetic microRNA, miRcxcr4, into the nucleus
38.
Fig. 1a shows that injection of capped CX reporter mRNA and
miRcxcr4 into the oocyte cytoplasm does not yield translation
activation, but instead exhibits modest (, 2-fold) repres-
sion. The requirement of nuclear injection for activation of CX
mRNA is specific for the corresponding microRNA and is not
induced by a control microRNA (Fig. 1a). The cellular levels of the
mRNA after nuclear versus cytoplasmic injections of the microRNA
did not correlate with the translation outcome (Fig. 1b;
38). Immuno-
precipitation of AGO revealed more substantial association (25%
compared to 4%) of the target reporter CX mRNA from nuclear-
injected samples compared to cytoplasmically-injected samples
(Fig. 1c). These results suggest that nuclear events enable the
assembly of an appropriate mRNP for translation activation.
AGO is present in the nucleus in immature Xenopus laevis
oocytes. We next examined the localization of factors expected to
participate in activation in the nuclei and cytoplasm after enzyma-
tically and manually defolliculating immature stage IV oocytes. The
fractionationwasverifiedbythepresenceofhistoneH4innucleiand
tubulinincytoplasm(Fig.2a).Nuclearandcytoplasmicextractswere
prepared inhigh salt buffer, thendiluted to 100 mMsalt followed by
sonication, which enables release of AGO from heavy cytoplasmic
complexes
38. In all other figures, we avoided sonication to preserve
thecomplex.ImportantlywefindthatAGOispresentinthenucleus
(Fig. 2a). These data are consistent with a nuclear presence of the
microRNPcomplex, previously reported forAGO2 and other AGOs
in mammalian cells where the complex is required for functions in
the nucleus
1,8,41,50,57,60. Flag-tagged clones of Xenopus AGO
38 and
hAGO2 expressed in rabbit reticulocyte lysate by in vitro
translation and purified over a Flag column were detected by the
Millipore AGO2 antibody (shown) or pan-AGO 2A8 antibody
38,
validating the use of these antibodies for detection of Xenopus
AGO (Fig. 2b). Additionally, immunoprecipitation of Xenopus
AGO with the 2A8 AGO antibody (recognizes all mammalian
AGOs but not PIWI
39) co-precipitated a similar-sized band as
detected by Western analysis with the Millipore AGO2 antibody
38.
Since 1) these oocytes were pre-defolliculated enzymatically and
manually and 2) AGO was detected in isolated nuclei (that are not
associated directly with follicles) and 3) AGO was detected by
immunoprecipitation and Western analysis with two antibodies
that recognize cloned Xenopus AGO (matching database NM_
001093519 and similar to EU338243
38) as well as human AGO2
(Fig. 2b), the AGO present in the nuclear compartment is poten-
tiallydistinctfromanAGOpreviouslydetectedinthecytoplasmand
primarily in the follicles
35.
An endogenous microRNA, miR16, is present in the oocyte
nucleus. We examined the localization of mature miR16, which is
required for translation activation of the Myt1 mRNA in immature
oocytes and for maintenance of the immature state
38. Stage IV
oocytes were fractionated; the fractionation was verified by the
presence of U6 snRNA in nuclei and 5.8S rRNA in cytoplasm
(Fig. 2c). Endogenous miR16 is substantially present in the nucleus
as detected by Northern analysis (Fig. 2c) and could be detected in
the cytoplasm with a more sensitive splint ligation assay
38(Fig. 2d).
As previously identified by splint ligation
38, the specific 59 trimmed
form of miR16, which activates Myt1 mRNA translation, is present
in the nucleus and to some extent in the cytoplasm (Fig. 2d). These
data suggest that some endogenous microRNAs, like miR16, have a
nuclear phase, which is consistent with the presence of AGO in the
nucleus.
Cytoplasmically-injected mRNAs are translationally activated
upon introduction of their targeting microRNA into the
nucleus. We noted in our previous study that microRNAs must be
injected into the animal pole/GV or nuclear side of the oocyte for
functional efficacy
38, consistent with the nuclear presence of miR16
(Fig.2c–d)toactivateMyt1mRNA.Weinvestigatedwhethernuclear
entry of a microRNA, mimicking the nuclear presence of miR16
implicated in activation of its target, Myt1
38 (Fig. 2c–d), would be
sufficient to induce microRNA-stimulated upregulation of its corre-
sponding target site-bearing reporter. In vitro transcribed reporters
were injected into the cytoplasm in this experiment while the
microRNA was injected into either the cytoplasm or the nucleus. A
control microRNA was tested in parallel. As observed in Fig. 3a,
reporter expression was stimulated only when the microRNA was
injected into the nucleus, whereas the control microRNA had no
effect. The reporter RNA levels did not correlate with the transla-
tion outcome and could not account for the expressionlevel changes
(Fig. 3b). Neither decreasing nor increasing mRNA or microRNA
concentrations could induce activation after cytoplasmic injection
38.
We had previously demonstrated that the microRNA injected into
the nucleus emerges into the cytoplasm after 1hr post-injection
38.
These results are consistent with the nuclear presence of endo-
genous AGO and miR16, which were previously demonstrated to
activate endogenous Myt1 mRNA expression
38 and suggest that
nuclear entry of the exogenous microRNA enables targeting of the
corresponding target mRNA for microRNA-mediated activation in
immature oocytes.
The endogenous target mRNA of miR16, Myt1 mRNA, associates
with AGO in the oocyte nucleus. Nuclear localization of micro-
RNAs and AGO (Fig. 2) has been observed in mammalian cells,
suggesting a nuclear phase for the microRNP complex
1,8,41,50,57,60.
Many mRNAs have been demonstrated to associate with RNA-
binding proteins in the nucleus
20,29,32, targeting the RNAs to their
appropriate fates in the cytoplasm; examples include Fragile X pro-
teins like FXR1
2,14,15,28,49. We investigated whether target mRNAs for
activation are uploaded into microRNPs in the nucleus, distingui-
shing them from target mRNAs for repression that are recruited cyto-
plasmically to the microRNP for downregulation
57. Consistently,
www.nature.com/scientificreports
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mRNA associated with AGO but not with control (RPA) antibody
(Fig. 4a–b). Cyclin A1 mRNA, which is repressed in immature oo-
cytes
32 and tRNAlys were not recruited by nuclear AGO and served as
controls (Fig. 4a). These data indicate that the nuclear AGO complex
recruits specific mRNAs that include targets for activation but not
mRNAs targeted for repression or non-related RNAs.
FXR1 associates with AGO in the oocyte nucleus. Previous reports
demonstrated a 160 kDa AGO2 complex in mammalian nuclei
41,
indicating the absence of GW182 (,182 kDa) in this complex
(AGO2, 90–100 kDa1GW182, 182 kDa) and suggesting the po-
tential presence of FXR1-iso-a, (56–60 kDa), which is required for
translation activation
38,53–56. Immunoprecipitation of AGO from
oocyte nuclei and cytoplasm revealed the association of Xenopus
Figure 1 | Upregulated expression requires injection of the microRNA and target mRNA into the nucleus. (a) Nuclear injections (black bars)
demonstrate upregulated expression of the CX reporter with miRcxcr4 and not with control let-7a while cytoplasmic injections demonstrate modest
repression (gray bars). Titrating the reporter (nuclear injections at 0.3 fmols or 0.03 fmols of reporter mRNA, shown 0.03 fmols) maintains activation
(injections performed with RNA as depicted above
38); cytoplasmic injections (at 0.03 fmols of reporter mRNA (shown) or lower at 0.001 fmols-0.0001
fmolsorhigherupto3.3fmols)shownosignificantchangeswhileincreasingtheinjectedmicroRNAlevelsdoesnotstimulate
38.MicroRNAhalf-livesand
export were demonstrated previously
38 (b) mRNA levels of the CX reporter normalized to Renilla reporter levels as analyzed by qRT-PCR do not reflect
the changes observed in the translation levels with nuclear or cytoplasmic injections. (c) AGO2 and control RPA antibody immunoprecipitates (Ips,
Western blots shown below) from nuclear or cytoplasmically injected (N-inj or C-inj, injected withCX reporter, Renilla reporter and miRcxcr4) oocytes
wereanalyzedbyqRT-PCRforthetargetCXreporter andcontrolRenillareporterscompared to10%Inputsamples.Approximately25%ofCXreporter
is detected associated with AGO2 in the nuclear injected oocytes compared to 4% in the cytoplasmically injected oocytes. The average values of three
replicates with standard deviations as error bars are shown in a-c.
www.nature.com/scientificreports
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indicating a nuclear AGO-FXR1 complex.
Overexpression of FXR1-iso-a leads to increased cytoplasmic AGO
levels and rescues upregulated expression with cytoplasmically in-
jectedtargets and microRNAs.Thenuclear localization ofmicroRNP
components (Fig. 2) suggests a nuclear phase for the microRNP, also
recently suggested for mammalian cells
1,8,41,50,57,60. Notably, an AGO-
FXR1 complex required fortranslation activationis more substantially
present in the nucleus than in the cytoplasm (Fig. 4b). These data
indicate that nuclear injections may be required to enable recruitment
of the microRNA and subsequently of the mRNA to the
predominantly nuclear AGO-FXR1 activation complex, leading to
downstream activation of the target mRNA in the cytoplasm. To test
this hypothesis, we asked whether increased expression of FXR1-iso-
a could rescue activation when the reporter mRNA and microRNA
are cytoplasmically injected. Fig. 5a shows that increased expres-
sion of FXR1-iso-a leads to rescue of activation with cytoplasmic
injections of CX mRNA and miRcxcr4 but not with a control
microRNA or upon expression of control GFP. The reporter RNA
levels did not correlate with the translation outcome and could not
account for the expression changes (Fig. 5c). Significantly, Western
blot analyses of nuclear and cytoplasmically fractionated samples
revealed an increased of AGO in the cytoplasm of FXR1-iso-a-
expressing oocytes compared to the GFP control-expressing oocyte
cytoplasm (Fig. 5b). We hypothesized that target activation resulted
from increased levels of FXR1-iso-a and AGO in the cytoplasm,
which would increase their interaction. Consistently, upon FXR1-
iso-a expression, increased presence of AGO-FXR1 complex was
observed in the cytoplasm (Fig. 5d), correlating with upregulated
translation of the cytoplasmically-injected reporter and corre-
sponding microRNA (Fig. 5a). In contrast, when control GFP was
expressed (Fig. 5d), no increase in cytoplasmic AGO levels was
observed and translation was not activated (Fig. 5a). These data
suggest that the presence of AGO-FXR1-iso-a complex enables
translation activation.
AGO2,FXR1andmicroRNAsarepresentinhumannuclei.Totest
whether these results were also true for mammalian G0 cells, we
fractionated human THP1 cells grown in cycling or G0 conditions.
ThenucleiandcytoplasmweresubjectedtoWesternblotanalyses,as
wellasqRT-PCRanalysesformicroRNAs.Thepurityofthefractions
was ascertained by probing for CBP80 and tubulin as nuclear and
cytoplasmic markers respectively. Fig. 6a shows Western blot anal-
yses of nuclear-cytoplasmically fractionated THP1 cells. Although
AGO2 levels is greater in the cytoplasm, we detect AGO2 in the
nuclei of growing cells as previously observed
1,8,41,50,57,60 and in G0
cells. AGO proteins have been previously reported to be associated
with CRM1, which is involved in nuclear export/import of specific
classes of RNAs, including some microRNAs
8,60. CRM1 transport is
sensitive to Leptomycin B (LMB) inhibition
8, while FXR1 bears a
nuclear localization signal (NLS) and a CRM1-dependent nuclear
export signal (NES) and was demonstrated to be exported partially
via CRM1
49. We find that LMB treatment causes partial retention in
nuclear levels of AGO2 and FXR1 but not of the controls, CBP80 or
tubulin, indicating that the signal observed upon nuclear fractio-
nation is presence in the nucleus and not contamination with
cytoplasmic material (Fig. 6a). RT-PCR analysis demonstrated the
presence of microRNAs in both nuclear and cytoplasmic compart-
ments (Fig. 6b, miR16 shown), as has been observed for several
microRNAs
8,23,30,44,57,60.
Nuclear AGO2 associates with an activated but not a repressed
target in G0 human cell nuclei. To test whether nuclear AGO2
recruits mRNAs selectively in the nucleus, AGO2 was immuno-
precipitated from G0 and non-G0 fractionated samples after in
vivo formaldehyde crosslinking
40,54 to freeze and preserve endo-
genous complexes. AGO2 immunoprecipitation (Fig. 7c) revealed
nuclear AGO2 associated with endogenous TNFa mRNA, a target
for G0 activation, in the nucleus of G0 cells but not in growing cells,
4 hrs after initiating serum-starvation (Fig. 7a, first panel). Cyclin E
mRNA,whichisrepressedinG0cells,isnotassociatedwithAGO2in
the nucleus but in the cytoplasm (Fig. 7a, second panel), as expected
for repressed RNAs
34,57. After a longer (8 hrs) serum-starvation,
TNFa mRNA is also found associated with AGO2 in the G0
cytoplasm (Fig. 7a, third panel). These data suggest that specific
mRNAs may be recruited to AGO complexes in the nucleus, which
enables them to be directed for activation in the cytoplasm. To
test whether nuclear AGO recruitment was specific for the target
sequence on TNFa mRNA, we tested Firefly reporters that bear 1)
a wild-type TNFa mRNA 39-UTR AU-rich element (ARE), which is
activated in G0 cells and 2) a mutant sequence (mtARE), which fails
to be activated
53–56. As shown in Fig. 7b, the ARE reporter, which is
activated in G0, associates considerably with nuclear AGO2 in G0,
suggestingthattheTNFamRNAisrecruitedbyAGO2inthenucleus
Figure 2 | Xenopus AGO and an endogenous microRNA, miR16, are
substantially present in the nucleus in immature oocytes. All extracts
(RNA and protein) and nucleus/cytoplasm isolation were prepared as
described
37,38(Methods).(a)Westernanalysisoftotal(T),nuclear(N)and
cytoplasmic (C) sonicated extracts from 20 immature, folliculated oocytes
using histone H4 as a marker for nuclei and tubulin as a cytoplasmic
marker. A lane was left after each fraction loaded to preclude signals from
spillover (observed with the tubulin signal in the lane between the
cytoplasm and total samples). AGO is more clearly detected when
cytoplasmic extracts are sonicated (shown) than in soluble cytoplasmic
extracts (all other figures)
38. (b) The antibody used for AGO analysis,
detects expression from Flag-tagged Xenopus AGO and human (hAGO2)
clones. In vitro transcription coupled translation RRL extracts (Promega)
were used to express control GFP, Flag-tagged Xenopus AGO and human
AGO2 (hAGO2) that were further subject to Flag purification and
subsequent Western analyses with the AGO2 antibody used (Millipore,
AGO2 antibody) and cross-checked with Flag antibody. (c) Northern
analysis of endogenous miR16 in nuclei and cytoplasm of immature
oocytes using probes against U6 as a nuclear marker and 5.8S rRNA as a
cytoplasmicmarker.EndogenousmiR16issubstantiallynuclear.(d)Splint
ligation reactions for detection of miR16/B3 59 trimmed form using a
specific B3 or a control bridging oligonucleotide (bridge splint) as
described previously
38 with nuclear and cytoplasmic oocyte RNA samples
from 20 oocytes each. In vitro synthesized miR16/B3 form was used as a
positive control and tRNA as a negative control.
www.nature.com/scientificreports
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55.Therefore,specificmRNAtargets
for activation, such as Myt1 (Fig. 4a) and TNFa (Fig. 7a–b), are
selectively recruited by a nuclear RNP containing AGO2; mRNAs
targetedforrepression,likeCyclinA1(Fig.4a)andCyclinE(Fig.7a),
are not.
FXR1-iso-a interacts with AGO2 in human nuclei. An mRNA
associated with an AGO2 complex that lacks GW182 is known to
derepress or activate mRNA expression
26,51 while FXR1-iso-a tethe-
ringtoanmRNAalsoleadstoitsactivatedtranslation
54.Apreviously
observed nuclear AGO2 complex of 160 kDa is too small to con-
tain GW182 (182 kDa)
41; the size of this complex is consistent
with AGO2 (90–100 kDa) plus FXR1-iso-a (56–60 kDa), similar to
the nuclear complex in oocytes (Fig. 4b). In vivo formaldehyde
crosslinking
40,54 followed by nuclear-cytoplasmic fractionation and
then immunoprecipitation of AGO2 from the nuclear and cyto-
plasmic fractions revealed that AGO2 interacts substantially with
FXR1 in the nucleus (cytoplasmic interaction can be observed upon
extended exposure but is reduced, data not shown) of cycling and G0
cells (Fig. 7c). In the cytoplasmic fraction of G0 cells, the antibody
immunoprecipitated less AGO, possibly due to the epitope being
masked. It remains possible that some amount of the complex, not
detected bythe antibody,isalsopresentinthe G0cytoplasm,whichis
consistent with its role in translation activation in G0. However, in
the cytoplasmic fraction of cycling cells, AGO is immunoprecipitated
at equal levels to that in the nucleus but FXR1 association is clearly
reduced compared to the nucleus, indicating that the complex is
primarily nuclear in such cells (Fig. 7c). Since TNFa and its regu-
latory microRNA are induced in G0 and reduced in asynchronous
cycling cells
53–56, the AGO-FXR1 complex does not recruit the TNFa
mRNA in cycling cells (Fig. 7a). Cytoplasmic AGO2 is associated
Figure 4 | Myt1, an endogenous target mRNA for activation by miR16,
associates with AGO in the nucleus where AGO interacts substantially
with FXR1, a co-factor required for activation. (a) Immunoprecipitation
ofXenopus AGO(anti-AGO/2A8antibody
39)orcontrolRPAfromnuclear
extracts followed by RT-PCRanalysis demonstrated that Myt1 mRNA was
specificallyassociatedwithAGOinthenucleus;CyclinA1mRNA,whichis
repressedinimmatureoocytes
32andtRNAlysservedasnegativecontrolsto
test specificity. (b) Immunoprecipitation of AGO (anti-AGO/2A8
antibody
39) or control (RPA antibody) from nuclear and cytoplasmic
extracts followed by Western blot analyses using anti-AGO2 (Millipore)
and anti-FXR1 (Abcam). AGO immunoprecipitates demonstrated
association with FXR1 in both the nucleus and cytoplasm, with more
substantial co-immunoprecipitation of FXR1 with AGO in the nucleus,
indicating the presence of a prominent nuclear AGO-FXR1
complex.
Figure 3 | UpregulatedexpressionrequiresinjectionofthemicroRNAintothenucleus. (a)Nuclearinjections(blackbars)ofmiRcxcr4butnotcontrol
let-7a (miRcontrol) with cytoplasmic injection of the CX and Renilla reporters rescues upregulated expression of the CX reporter unlike cytoplasmic
injections ofmiRcxcr4,where modestrepression isobserved (gray bars);injections wereperformed withtranscribedRNA asdepictedabove. (b)mRNA
levels of the CX reporter normalized to Renilla reporter levels as analyzed by qRT-PCR with nuclear or cytoplasmic injections of the microRNA do not
correlate with translation changes. The average values of three replicates with standard deviations as error bars are shown in a-b.
www.nature.com/scientificreports
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41) in particular, with the nega-
tive regulator, GW182
4,10,13,16,33,58, and microRNAs
57 and are repres-
sive. Immunoprecipitation with antibodies against the GW182/P body
(anti-18033
58,59) to co-precipitate RNAs with repressive GW182
complexes did not detect TNFa mRNA in the nucleus or cytoplasm
(Supplementary Fig. S1, first panel). Cyclin E mRNA, which is repressed
in G0
34, was detected associated with GW182 complexes, in particular,
in the cytoplasmic but not in the nuclear complex in G0 cells. These
data indicate that repressed mRNAs like Cyclin E, but not activated
mRNAs like TNFa are recruited to cytoplasmic GW182-AGO2
repressive complexes (Supplementary Fig. S1, second panel and
Fig. 7a). A similar experiment could not be performed with anti-
FXR1-iso-a
53–56, due to the lack of isoform-specific antibodies.
Compartmentalization may enable selective recruitment of specific
Figure 5 | Expression of FXR1-iso-a to overexpress FXR1 levels increases the cytoplasmic levels of AGO and rescues translation activation of CX
mRNAbymiRcxcr4,injectedcytoplasmicallyintooocytes. (a)OocyteswerenuclearinjectedwithDNAplasmidstoexpresseitherGFPcontrolorFXR1-
iso-ainoocytesandweresubsequentlycytoplasmicallyinjectedwithmiRcxcr4orcontrollet-7a,CXandRenillareporters. Upregulatedexpressionofthe
CX reporter in the presence of miRcxcr4 was rescued upon overexpression of FXR1-iso-a but not with GFP control or with the control microRNA. (b)
Westernblotanalysisofnuclei(N)andcytoplasm(C)extracts(solubleextractsthatwerenotsonicated)from20immature,folliculatedoocyteseachthat
were injected with DNA plasmids to express either GFP control or FXR1-iso-a. Histone H4 and actin served as controls. FXR1-iso-a expression leads to
increased FXR1 levels as well as increased cytoplasmic levels of AGO. AGO is more clearly detected when cytoplasmic extracts are sonicated (Fig. 2a)
comparedtosolublecytoplasmicextracts(thisfigure)
38.(c)mRNAlevelsoftheCXreporternormalizedtoRenillareporterlevelsasanalyzedbyqRT-PCR
with GFP or FXR1-iso-a expression do not correlate with translation changes in (a). (d) AGO2 (Wako) immunoprecipitates from cytoplasmic samples
expressing either GFP control or FXR1-iso-a were analyzed for co-immunoprecipitation of FXR1. Increased levels of FXR1 were immunoprecipitated
with samples overexpressing FXR1-iso-a. RPA antibody immunoprecipitation served as an antibody control. Increased AGO and FXR1 levels can be
observedintheInputlaneofthesamplesoverexpressingFXR1-iso-acomparedtoActinlevelsusedasaloadingcontrol;theAGOantibodyamounts(1/3)
used for immunoprecipitation are limiting. The average values of three replicates with standard deviations as error bars are shown in a, c.
www.nature.com/scientificreports
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complexes, previously demonstrated to be required for activation.
These RNAs may be specifically induced or mobilized in G0 and
therefore, are recruited in the nuclear compartment while pre-
existing, proliferation-associated mRNAs are cytoplasmic and not re-
cruited by the nuclear activation complex (TNFa mRNA is recruited
by the nuclear activation complexb u tC y c l i nEm R N Ai sn o t ,F i g .7 a –
b)
34,53–56.
Overexpression of FXR1-iso-a leads to increased cytoplasmic AGO2
levels and rescues upregulation of expression by microRNAs in
asynchronous, low-density proliferating cells. We had earlier ob-
served that overexpression of FXR1-iso-a in low density proliferating
cells promoted translation
54, similar to the rescue of activation of
cytoplasmically-injected reporters and microRNA after FXR1-iso-a
expression in oocytes (Fig. 5a). Significantly, nuclear-cytoplasmic frac-
tionation of low density proliferating cells (Fig. 8a, histone and tubulin
serve as markers for the nucleus and cytoplasm, respectively), overex-
pressing FXR1-iso-a (Fig. 8a, FXR1) but not control GFP, demon-
strated increased presence of AGO2 in the cytoplasm (Fig. 8a, AGO2,
short exposure) with some increase also detected in the nucleus.
A l t h o u g hm o r eA G O 2a n dF X R 1a r ep r e s e n ti nt h ec y t o p l a s mt h a n
in the nucleus of mammalian cycling c e l l s( F i g .6 a ) ,a nA G O 2 - F X R 1 -
iso-a complex was not significantly detected in the cytoplasm (Fig. 8b,
GFP and Fig. 7c) of asynchronous, low-density proliferating cells
(slowly proliferating, mostly lag phase cells) and is reduced in oocytes
(Fig. 4b). Upon increased expression of FXR1-iso-a in asynchronous,
low density proliferating cells, an AGO2-FXR1-iso-a complex (Fig. 8b,
FXR1 lanes, anti-FXR1) could be immunoprecipitated from cyto-
plasmic extracts. Consistently, increased expression of FXR1-iso-a led
to activation of translation of CX reporter mRNA mediated by
miRcxcr4 but not by a control microRNA (Fig. 8c) in these asynch-
ronous, low-density proliferating cells. In high density proliferating cells,
repression is dominantly observed with microRNAs
24,53,55,56 and over-
expression of FXR1-iso-a non-specifically increased general translation
(data not shown). These results suggest that the increased levels of the
AGO2-FXR1-iso-a complex facilitate activation. This occurs natu-
rally in nuclei with nuclear recruitment of specific mRNAs in
oocyte nuclei and in mammalian G0 cells (Figs. 1–4, 6–7) but
can be induced in the cytoplasm in oocytes and in low-density
proliferating mammalian cells through overexpression of FXR1-
iso-a (Figs. 5, 8).
Discussion
Translational activation of specific mRNAs in alternative cell states,
such as the immature oocyte and mammalian G0 cells, provides a
meanstomaintainthatstateforextendeddurations
45.Theimmature
oocytepost-transcriptionallyregulatestheexpressionofgenesessen-
tial for maintaining the immature state and for subsequent oocyte
maturation
19. MicroRNPs can activate translation of specific repor-
ters in G0 mammalian cells
31,52–54. MicroRNP-controlled activation,
mediated by AGO and miR16, is required in part to maintain the
immature state in the naturally quiescent-like Xenopus laevis imma-
ture oocyte
38. Here, we have found that activation involves selective
microRNA and target recruitment by a distinct, nuclear AGO-FXR1
complex in immature oocytes and G0 human cells, coincident with
the requirement for a compartmentalized, nuclear phase to enable
microRNA-mediated upregulation of specific reporter mRNAs in
immature Xenopus laevis oocytes.
A primary feature common to the two systems—quiescent cells
andimmature oocytes—is thepresence of anintactnucleus. Wefind
that microRNAs and their target mRNAs injected into the oocyte
nucleus are recruited for translation activation by microRNPs
(Figs. 1,3), while those injected into the cytoplasm or into mature
oocytes (lacking nuclei) lead to repression, consistent with the
absence of a nuclear phase or of an intact nucleus after Germinal
vesiclebreakdown(GVBD)
38orduringthecellcycle
56.Theendogen-
ous microRNA, miR16, is detected in the nucleus (Fig. 2C–D), as are
AGO and FXR1 (Figs. 2a–4b), which are required for activation of a
target mRNA
38. MicroRNAs such as miR206, implicated in specific
activation in quiescent-like conditions
31, have also been observed in
mammalian cell nuclei
44. While worms express an Argonaute with a
specialized NLS
21, human AGO2 along with associated microRNAs
can be imported into the nucleus
8,41,50,57,60 via Importin 8 and asso-
ciations that lead to CRM1-mediated transport
8,57,60. Importin 8
antisenseintheoocyteaffectedviabilityandcouldnotbetested(data
not shown). AGO2 and FXR1 demonstrated partial nuclear reten-
tion (Fig. 6a) upon LMB blockage of CRM1, similar to the effects
previously observed with microRNAs and FXR1 with LMB
Figure 6 | AGO2, FXR1 and microRNAs like miR16 are present in mammalian nuclei and are partially restricted by LMB inhibition of the CRM1
export pathway. (a) Western analysis of AGO2 and FXR1 in nuclear and cytoplasmic extracts from proliferating (Cycling) and G0 THP1 cells that were
untreated or treated (1)with LMB to inhibit the CRM1 pathway
8,49. CBP80 served as a marker for nuclei and tubulin as a cytoplasmic marker. (b)
MicroRNAs are present in the nucleus and cytoplasm as previously published
8,23,30,44,57,60. MiR16 levels in proliferating (non-G0) and G0 cell nuclei and
cytoplasm as analyzed by qRT-PCR. The average values of three replicates with standard deviations as error bars are shown.
www.nature.com/scientificreports
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were observed after in vivo formaldehyde crosslinking
40,54 followed by nuclear-cytoplasmic fractionation and immunoprecipitation. (a)
Immunoprecipitation of AGO2 (Wako) or control IgG from nuclear and cytoplasmic extracts of proliferating (Cycling) and G0 THP1 cells followed by
RT-PCR analysis demonstrated that TNFa mRNA was specifically associated with AGO2 exclusively in G0 nuclei after 4 hrs of serum-starvation
induction of G0 (TNFa, first panel, 4 hrs G0) and also in the G0 cytoplasm later at 8 hrs of serum-starvation (TNFa, third panel, 8 hrs G0). Cyclin E
mRNA, which is repressed in G0
34, served as a control and is not present in the nuclear complex but in the G0 cytoplasmic complex (Cyclin E, second
panel,4 hrsG0;themRNAisdownregulatedandbelowdetectionby8 hrs).Input(INP)510%ofthesample.(b)G0HEK293cellsweretransfectedwith
reporters that bear the AU-rich target sequence of TNFa mRNA (TNFa ARE, sufficient for activation in G0
54,55) or a mutated sequence (mtARE, non-
functionalforactivation)
54,55.ImmunoprecipitationofAGO2orcontrolIgGfromnuclearandcytoplasmicextractsfromtransfectedlateG0cellsfollowed
by RT-PCRanalysis demonstrated that the AREreporter wasassociated substantially withAGO2 inG0 nuclei, withsome association inG0 cytoplasm as
expected at late G0, similarto (a). No association was observed withthe mutated (mtARE) reporter; tRNAlys andRenilla servedas controls. Theaverage
values of three replicates with standard deviations as error bars are shown. (c) Western analyses of immunoprecipitates from 4hr G0 and cycling (Cyc)
samples from (a) using anti-AGO2 (Millipore) and anti-FXR1. Input (INP) 510% of the sample. A non-specific band immunoprecipitated with anti-
AGO2andIgGintheAGO2WesternblotanalysisbelowthespecificAGO2band.Anti-FXR1recognizesseveralbandsintheInputlanerepresentingseven
isoforms and modifications. In G0 cytoplasmic fractions (Cyto-G0), the antibody immunoprecipitated less AGO, possibly due to the epitope being
masked.Incyclingcellcytoplasmicfractions(Cyto-Cyc),AGOisimmunoprecipitated atequallevelstothatinthenucleusbutFXR1associationisclearly
reduced. AGO2-FXR1 complex is substantially present in the nucleus.
www.nature.com/scientificreports
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8,49,57,60. The partial retention observed is likely due to only
partial inhibition of CRM1 export by LMB
8,49 and not complete loss
of CRM1 functions upon CRM1 depletion
60. The AGO-FXR1 com-
plex was previously detected in multiple AGO complex purifica-
tions
9,25. While tethering AGO2 or GW182
4,54 to a reporter in
cycling cells promotes repression, tethering FXR1 does not
54. In qui-
escent conditions, FXR1 and AGO2 promoted expression of the
tethered reporter
54, dependent on each other, indicating that the
complex was required for activation. These studies suggest a com-
partmentalized role for a specific AGO2-FXR1-iso-a complex in the
nucleusthatleadstotranslationactivationofrecruitedmRNAsinthe
cytoplasm in G0 and immature oocytes.
Although more AGO2 is present in the cytoplasm than in the
nucleus of mammalian cells (Fig. 6) and the target mRNA is stable
inoocytesinthenucleusorcytoplasm
38(Fig.1b),cytoplasmicAGO2
isboundinlargercomplexes(upto2–3MDa
41)inparticular,withthe
negative regulator, GW182
4,10,13,16,33,58, and microRNA
57, and is
repressive. GW182 can be detected in mammalian nuclei; however,
thenuclearAGOinteractingcomplexdetectedissmaller(160 kDa
41)
and therefore lacks the repressive factor GW182. AGO2-GW182
interaction is altered in G0
58 and mouse oocytes
18,36. Immunopre-
cipitation with anti-18033 to detect P bodies/GW182
58,59 in oocytes,
co-immunoprecipitated an AGO detected with an antibody against
the PIWI domain (but not with the AGO2 antibody used to detect
ourcloneaspreviouslypublished
35)inthecytoplasm,suggestingthat
AGO-GW182 interaction was detected with potentially a distinct
AGO in the cytoplasm. Tagged proteins could not be used for better
detectionofGW182only(andnotGW182/Pbody complexes
58,59)as
expressionoftaggedGW182hasadominantrepressive effect, which
precludes its use to study endogenous complexes during activation
(data not shown). Anti-18033 does not co-precipitate FXR1 in
oocytes and mammalian cells while GW182 was not detected in
FXR1 immunoprecipitates (data not shown). These data indicate
separate AGO2 interactions and complexes with the repressive co-
factor, GW182, and with the activating co-factor, FXR1-iso-a, lead-
ing to distinct translation outcomes of associated transcripts.
Endogenous AGO2-FXR1-iso-a complex was not detected in the
cytoplasm (Fig. 8b, GFP and Fig. 7c) of asynchronous, low density
proliferating cells and was reduced in oocyte cytoplasm (Fig. 4b).
Overexpression of FXR1-iso-a led to increased association with
AGO2 in the cytoplasm of oocytes and low density slowly prolif-
eratingcells(Figs.5d,8b),substitutingforthenuclearAGOcomplex
Figure 8 | Expression of FXR1-iso-a to overexpress FXR1 levels increases the cytoplasmic levels of AGO2 and rescues translation activation of CX
mRNA by miRcxcr4 inasynchronous, low density proliferating cells. (a) Western analysis of nuclear and cytoplasmic extracts from asynchronous, low
density proliferating HEK293 cells (slowly proliferating, mostly lag phase cells) that express either GFP control or FXR1-iso-a (FXR1, 1mg transfected/
1x10
5cells/ml). FXR1-iso-aoverexpression leadstoincreasedFXR1levelsaswellasincreasedcytoplasmicAGO2levelswithsomeincreaseinthenucleus
(short exp5short exposure of the saturated levels present in the original exposure above). Histone H4 and tubulin served as nuclear and cytoplasmic
markers, respectively. (b) Immunoprecipitation of AGO2 from cytoplasmic extracts expressing FXR1-iso-a or GFP in asynchronous, low density
proliferatingcellsdemonstrated increasedinteraction betweenAGO2andFXR1-iso-auponFXR1-iso-abutnotGFPexpression.(c)Expressionofeither
GFPcontrolorFXR1-iso-ainasynchronous,lowdensityproliferatingcellsthatweresubsequentlytransfectedwithmiRcxcr4orlet-7a(control),CXand
Renilla(Ren)reporters,demonstratedrescuedupregulatedexpressionoftheCXreporterinthepresenceofmiRcxcr4uponoverexpressionofFXR1-iso-a
but not GFP control. The fold activation depicted (fold activation 5 the Firefly Luciferase translation value of CX reporter observed in the presence of
miRcxcr4 normalized to Renilla over the Luciferase value of CX with control Let-7a microRNA normalized to Renilla that were further normalized to
their RNA levels, which do not change significantly as described previously)
54 are compared between samples overexpressing GFP or FXR1-iso-a. The
average values of three replicates with standard deviations as error bars are shown.
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the cytoplasm upon FXR1-iso-a overexpression (increased AGO2
export, translation and/or protein stability mediated by FXR1-iso-a,
Figs. 5b, 8a) remains to be investigated. Increased AGO2-FXR1-iso-a
complexes (Figs. 5d, 8b), provide the cytoplasm with activation com-
plexes to enable recruitment of the microRNA and mRNA and con-
sequent activation (Figs. 5a, 8c). These data indicate that increased
presence of the activation complex, naturally compartmentalized in
the nucleus or upon exogenous FXR1-iso-a overexpression, contri-
butes to selective recruitment for activation of distinct mRNAs by
m i c r o R N A s( F i g s .4 ,5 ,7 ,8 ) .
ManymRNAsintheoocyteandinmammaliancellsassociatewith
specific RNA-binding proteins in the nucleus that then dictate ap-
propriate fates in the cytoplasm
20,29,32. microRNAs
8,23,30,44,57,60, micro-
RNPs
1,8,41,50,57,60 and RNA binding proteins
1,2,8,14,15,28,41,49,50,57,60, in par-
ticular, FXR1
2,14,15,28,49, have been demonstrated to associate with
target mRNAs in the nucleus. Specific microRNAs in G0, compart-
mentalized in the nucleus, may selectively associate with the nuclear
AGO2-FXR1-iso-a complex, to recruit target mRNAs, such as Myt1
and TNFa mRNAs, for upregulated translation (Figs. 2c–d, 4, 6–7).
These RNAs are induced or mobilized in G0 for conducting G0-
relatedfunctionsandmaythusbeavailableinthenucleusforrecruit-
ment. Cytoplasmic microRNAs (induced in G0 or pre-existing) are
recruited into repressive cytoplasmic AGO complexes
57 that lack
AGO2-FXR1-iso-a (Figs. 4b, 7c, cytoplasm FXR1 blot), thereby,
directing them towards downregulation of pre-existing target
mRNAs associated with proliferation, such as Cyclin E mRNA,
which was translated during the cell cycle prior to arrest
11,34 and
would be cytoplasmically present (Fig. 7a and Supplementary Fig.
S1, Cyclin E-recruitment by AGO2 and GW182 complex in G0
cytoplasm). Regulated expression and modifications of the
microRNP, microRNA or mRNA in G0 may also contribute to
enable specific recruitment and activation
53–56,26,38. Our data suggest
that in immature oocytes and human G0 cells, the nuclear phase of
microRNAs and AGO2-FXR1-iso-a complex (Figs. 2–4, 6–7) is con-
sistent with selective recruitment to the nuclear AGO2-FXR1-iso-a
complex, which may direct specific targets to undergo translation
upregulation by microRNAs (Figs. 1, 3, 4, 7)
38,54,55.
Methods
Oocytes. Oocytes (Immature, folliculated stages IV-V oocytes) were harvested
from human chorionic gonadotropin (hcG)-stimulated frogs by partial
ovariectomy
37 and manipulated as described previously
37–38. The pre-stimulated
frogs were obtained from NASCO (WI). The oocyte removal and animal handling
protocol
37 adhered strictly to the institutionally approved guidelines and
regulations. The animal handling and oocyte removal protocols were reviewed,
approved and renewed annually by the Subcommittee on Research Animal Care
(SRAC), which serves as the Institutional Animal Care and Use Committee
(IACUC) for MGH.
Injections were performed using Drummond Nanojet II system with volumes of
18nls for reporters and plasmids (into the nucleus or cytoplasm). 18 nls containing
0.0625–0.125 ngs DNA plasmid, 0.3 or 0.03 fmols in vitro-transcribed Luciferase
reporter mRNAs, 375 fmols microRNA were injected per oocyte with diluted blue
dextran dye to visualize accurate delivery into the GV prior to harvest of the oocytes.
Foroverexpression,2.5 ngsofDNAplasmid(or7 ngsofinvitro-transcribed,capped
mRNA) of FXR1-iso-a or GFP was used. Translation was assayed with a time course
ranging from 1–6 h and compared at 4 h in hcG-treated oocytes. All injections were
conducted with folliculated immature stage IV-V oocytes. The injections were per-
formed carefully to avoid escape of RNAs into the cytoplasm that would produce
erroneously high background readings. All extracts (RNA and protein) and nucleus/
cytoplasmisolationwerepreparedasdescribedbelow
37,38topreventcontaminationof
the samples with follicular material.
Plasmids and reporters. All plasmids, reporters and microRNAs used are described
in
38. Figs. 1,3 and 5 utilized in vitro-transcribed luciferase reporter RNAs.
Unadenylated reporters were used as polyadenylated reporters precluded analysis of
stimulated expression
38.
Luciferase assay. Extract preparation and luciferase assays were performed as
describedinthemanufacturer’s protocol(Promega).Oocytesweremanuallycrushed
in PLB buffer (Promega) and clarified by centrifugation at 2000 rpm for 5 minutes.
The average ratios of luciferase values from at least three replicates are depicted with
the standard deviations as error bars. RNA levels were assessed in each experiment
separately (notused tonormalize the values graphed), performed at least three times.
Protein and RNA analyses. Total oocyte extracts, immunoprecipitations and RNA
analyses are described
37,38. Folliculated oocytes were injected and incubated prior to
harvest. All extracts (RNA and protein) and nucleus/cytoplasm isolation were
prepared after collagenase treatment of the harvested oocytes followed by manual
defolliculation and examination to ensure complete defolliculation of oocytes
37,38 to
prevent contamination of the samples with follicular material. For all gels, equal
numbers (20) defolliculated oocytes upon harvest, isolated as described in
37,38 were
run in each lane.
Extract preparation and oocyte immunoprecipitations. Soluble extracts
38 for
immunoprecipitations were prepared using 20 oocytes per sample of total oocytes,
isolated nuclei and cytoplasm that were prepared as extracts after manual
defolliculation as well as collagenase treatment of the oocytes and examination to
ensure complete defolliculation prior to extract preparation (as described in
37,38)t o
prevent contamination of the samples with follicular material. The oocytes, nuclei
and cytoplasm were manually crushed in 150 ml of lysis buffer X (100 mM NaCl,
40 mM Hepes 7.8, 6 mM MgCl2, 0.05% NP40) and adding DTT and PMSF to
1 mM each. The extract was incubated on ice for 5 minutes. The oocytes were
crushed, NaCl added to 400 mM for 2 minutes to get high salt conditions to
extract nuclear material, then crushed followed by correction buffer (lysis buffer X
without salt) to bring back the salt concentration of the extract to 100 mM. The
extract was then incubated on ice for 30 minutes. Low amounts of AGO are
present in extracts if the extracts are clarified at 10000 g. Therefore, a low-speed
centrifugation (2000 g) was used to clarify the extracts for immunoprecipitations.
A pipette tip was used to clear the lipid layer and the clarified extract removed to a
new tube. The immunoprecipitations were carried out with these soluble lysates of
40–100 oocytes using anti-pan-AGO/2A8 antibody (Santa Cruz)
39 while all
Western analyses were with anti-AGO2 antibody (Millipore) with soluble extracts
of 20 oocytes (Figs. 1, 4–5).
To analyze AGO levels by Western blotting, in particular, in the cytoplasm where
AGO is present in large complexes (2–3 MDa;
41, total oocytes (defolliculated upon
harvest) were prepared as sonicated lysates only for Fig. 2a. Total defolliculated
oocytes, nuclei and cytoplasm were lysed and extracted on ice in lysis buffer X as
described above for soluble extracts, followed by clarifying the sample at 2000 g for 5
minutes to separate out and remove the lipid/polysaccharide layer. The rest (lysate
andresuspendedpellet)weremixed,madeupto0.3%SDS,extractedonice,sonicated
for 10 s with 30 s cooling 3 times, and the subsequent sonicated lysate clarified by
centrifugation at 2000 g for 5 minutes to remove debris, followed by acetone pre-
cipitation of the sonicated samples
38.
The acetone precipitates of both soluble and sonicated extracts were resuspended
in SDS loading buffer and fractionated by 4–20% gradient SDS-PAGE followed by
Western blotting and further analyses. Xenopus samples were probed with anti-
XenopusAGO/AGO2(anti-AGO2,Millipore),anti-FXR1(Abcam),anti-HistoneH4
(Cell Signaling), anti-Tubulin (Santa Cruz), and anti-Actin (Sigma).
For immunoprecipitations
38, one half of the soluble extract was diluted 2-fold with
lysis buffer X and incubated with 20 ml of anti-AGO/2A8 antibody or anti-RPA as
control antibody overnight with nutation at 4uC. The samples were then transferred
to new tubes, 40 ml of protein G agarose (pre-blocked for 1 hr with 1mg/ml of tRNA
andglycogen)added,followedbyincubationwithnutationat4uCfor1 hrafterwhich
the beads were concentrated by centrifugation at 6000 g for 10 minutes. The agarose
beads were washed with lysis buffer X without DTT and glycerol, with 0.1% NP40
fourtimes, oncewithRIPAbuffer(1%NP-40,0.5%Nadeoxycholate,150 mMNaCl,
50 mM Tris pH 7.5, 0.05% SDS) and then transferred to a new tube for acetone
precipitation followed by or directly resuspended in 6x loading buffer with 0.4 M
DTT. For immunoprecipitations for RT-PCR assays (Figs. 1, 3, 4A), 0.5 ml of RNasin
was added to the extract before incubation with the antibody and the immunopre-
cipitates were used for RNA extraction/analyses. 40–100 oocytes were used for each
sample.
RT-PCR analyses. cDNA synthesis was performed using Random Primers
(Invitrogen) and the cDNA was subjected to PCR amplification with 526C annealing
and 28–35 cycles for different cDNA preparation yields. For mammalian samples,
primers to endogenous mRNAs, TNFa (TNF360-5:
CCCAGGGACCTCTCTCTAATCA and TNF470-3:
AGCTGCCCCTCAGCTTGAG) and as a control, to tRNAlys (trnalys-5:
GCCCGGATAGCTCAGTCGGTAGAG and trnalys-3:
CGCCCGAACAGGGACTTGAACCC), exogenously introduced Firefly, FF-F3
(TTCCATCTTCCAGGGATACG) and FF-R3 (ATCCAGATCCACAACCTTCG)
and, as a control, Renilla, Ren1 (CCATGATAATGTTGGACGAC) and Ren2
(GGCACCTTCAACAATAGCATTG) were used. For oocytes, endogenous mRNA
Myt1 was analysed using Myt3245-5 (CAGTATTGTTGAATATATCATGTAACC)
andMyt3245-3(CTGCCATTATCAAGCAGGAGCACTGC)andCyclinA1primers
as described previously
32. The endogenous control used was Xenopus laevis tRNAlys,
(tRNAlys-5: CCCGCATAGCTCAGTCGGTAGAGC and tRNAlys-3:
CCCGAACAGGGACTTGAACCC).
Quantitative RT-PCR. Random hexamer and FF3END3 were used for cDNA
synthesis. FF3END3 (caatttggactttccgcccttcttggc) and FF10-5
(ggattacgtggccagtcaagtaacaaccg) were used to amplify CX Firefly reporter mRNA at
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 842 | DOI: 10.1038/srep00842 10the 39 end of the Firefly coding region. Human miR16 levels were detected using the
TaqMan-microRNA Reverse Transcription kit and TaqMan-microRNA Assay
(Applied Biosystems) according to the manufacturer’s instruction.
Mammalian cell fractionation, immunoprecipitation, crosslinking procedures.
These procedures were conducted as described previously
46,54,55 and is detailed in the
Supplementary Information.
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